The role of m6A methylation in osteosarcoma biological processes and its potential clinical value

被引：0
作者：
Yanjiao Wu
Zhiyun Wang
Jianlin Shen
Wei Yan
Shurong Xiang
Huan Liu
Wenhua Huang
机构：
[1] Southern Medical University (The First People’s Hospital of Shunde),Shunde Hospital
[2] Southern Medical University,Guangdong Provincial Key Laboratory of Medical Biomechanics, School of Basic Medical Sciences
[3] Southern Medical University,Guangdong Engineering Research Center for Translation of Medical 3D Printing Application
[4] Southern Medical University,Guangdong Innovation Platform for Translation of 3D Printing Application
[5] Affiliated Traditional Chinese Medicine Hospital,Department of Orthopaedics
[6] Southwest Medical University,The Precision Medicine Institute, The Third Affiliated Hospital
[7] Southern Medical University,Department of Anatomy
[8] Hebei Medical University,undefined
来源：
Human Genomics | / 16卷
关键词：
m6A modification; Osteosarcoma; Epigenetics; Writers; Erasers; Readers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and young adults and has a poor prognosis. Recent developments in the field of high-throughput sequencing technology, particularly in methylated RNA immunoprecipitation sequencing (MeRIP-seq), have led to renewed interest in RNA methylation. Among the various RNA modifications, N6-methyladenosine (m6A) modifications are the most common. Emerging evidence suggests that m6A methylation can affect the complexity of cancer progression by regulating biological functions related to cancer. In this review, we will shed light on recent findings regarding the biological function of m6A methylation in OS and discuss future research directions and potential clinical applications of RNA methyltransferases in OS.
引用
收藏
相关论文
共 392 条
[1]  
Lin YH(2017)Osteosarcoma: molecular pathogenesis and iPSC modeling Trends Mol Med 23 737-755
[2]  
Jewell BE(2021)Future directions in the treatment of osteosarcoma Cells-Basel 10 172-50
[3]  
Gingold J(2019)Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Eur J Cancer 109 36-581
[4]  
Lu L(2006)Osteosarcoma: anatomic and histologic variants Am J Clin Pathol 125 555-1321
[5]  
Zhao R(2020)Autophagy regulation bymicroRNAs: novel insights into osteosarcoma therapy IUBMB Life 72 1306-50
[6]  
Wang LL(2021)Mechanisms of resistance to conventional therapies for osteosarcoma Cancers 18 39-2872
[7]  
Smrke A(2018)Current and future therapeutic approaches for osteosarcoma Expert Rev Anticancer Ther 46 2844-107
[8]  
Anderson PM(2017)Epigenetic modification of nucleic acids: from basic studies to medical applications Chem Soc Rev 217 101-679
[9]  
Gulia A(2018)Deletion of the epigenetic regulator GcnE in Aspergillus niger FGSC A1279 activates the production of multiple polyketide metabolites Microbiol Res 73 664-917
[10]  
Gennatas S(2020)Epitranscriptomics in liver disease: basic concepts and therapeutic potential J Hepatol 20 896-3256
12345678910